BiondVax Pharmaceuticals Ltd ADR is a biotechnology business based in the US. BiondVax Pharmaceuticals Ltd ADR shares (BVXV) are listed on the NASDAQ and all prices are listed in US Dollars. BiondVax Pharmaceuticals Ltd ADR employs 33 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy BiondVax Pharmaceuticals Ltd ADR stock
How to buy BiondVax Pharmaceuticals Ltd ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – BVXV. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy BiondVax Pharmaceuticals Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
BiondVax Pharmaceuticals Ltd ADR stock price (NASDAQ: BVXV)
Use our graph to track the performance of BVXV stocks over time.BiondVax Pharmaceuticals Ltd ADR shares at a glance
Latest market close | $0.69 |
---|---|
52-week range | $0.62 - $1.42 |
50-day moving average | $1.17 |
200-day moving average | $1.79 |
Wall St. target price | $39.00 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-2.35 |
Is it a good time to buy BiondVax Pharmaceuticals Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
BiondVax Pharmaceuticals Ltd ADR price performance over time
Historical closes compared with the close of $0.69 from 2023-11-08
1 week (2024-07-13) | N/A |
---|---|
1 month (2024-06-20) | N/A |
3 months (2024-04-20) | N/A |
6 months (2024-01-20) | N/A |
1 year (2023-07-24) | -48.89% |
---|---|
2 years (2022-07-22) | -43.44% |
3 years (2021-07-23) | 2.86 |
5 years (2019-07-24) | 6.23 |
BiondVax Pharmaceuticals Ltd ADR financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -30.89% |
Return on equity TTM | -5601.53% |
Profit margin | 0% |
Book value | $-1.96 |
Market Capitalization | $5 million |
TTM: trailing 12 months
BiondVax Pharmaceuticals Ltd ADR share dividends
We're not expecting BiondVax Pharmaceuticals Ltd ADR to pay a dividend over the next 12 months.
Have BiondVax Pharmaceuticals Ltd ADR's shares ever split?
BiondVax Pharmaceuticals Ltd ADR's shares were split on a 1:10 basis on 24 November 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BiondVax Pharmaceuticals Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for BiondVax Pharmaceuticals Ltd ADR shares which in turn could have impacted BiondVax Pharmaceuticals Ltd ADR's share price.
BiondVax Pharmaceuticals Ltd ADR share price volatility
Over the last 12 months, BiondVax Pharmaceuticals Ltd ADR's shares have ranged in value from as little as $0.6194 up to $1.42. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BiondVax Pharmaceuticals Ltd ADR's is 2.3662. This would suggest that BiondVax Pharmaceuticals Ltd ADR's shares are significantly more volatile than the average for this exchange and represent a higher risk.
BiondVax Pharmaceuticals Ltd ADR overview
BiondVax Pharmaceuticals Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. .
Frequently asked questions
nullWhat percentage of BiondVax Pharmaceuticals Ltd ADR is owned by insiders or institutions?
Currently 20.017% of BiondVax Pharmaceuticals Ltd ADR shares are held by insiders and 10.687% by institutions. How many people work for BiondVax Pharmaceuticals Ltd ADR?
Latest data suggests 33 work at BiondVax Pharmaceuticals Ltd ADR. When does the fiscal year end for BiondVax Pharmaceuticals Ltd ADR?
BiondVax Pharmaceuticals Ltd ADR's fiscal year ends in December. Where is BiondVax Pharmaceuticals Ltd ADR based?
BiondVax Pharmaceuticals Ltd ADR's address is: Jerusalem BioPark Building, Jerusalem, Israel What is BiondVax Pharmaceuticals Ltd ADR's ISIN number?
BiondVax Pharmaceuticals Ltd ADR's international securities identification number is: US09073Q1058 What is BiondVax Pharmaceuticals Ltd ADR's CUSIP number?
BiondVax Pharmaceuticals Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 09073Q105
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
Put options explained
Learn the basics of put options: what they are, how they work and a few examples.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
11 apps like Webull you need to consider
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question